BridgeMD
New treatment option for Parkinson's Disease
Official title Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
ClinicalTrials.gov ID: NCT04179695
What this study is testing
- What it's testing
- PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
- Time commitment: about 7 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Adult men and women with all stages of PD
- Without severe chronic neurological or mental or psychiatric pathology
- Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22)
- able to come (alone or accompanied) to consultation
- Affiliate or beneficiary of a social security scheme
You likely can't join if
- Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the...
- Subject under tutelage or curtailer.
- Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.
See the full eligibility criteria
- Adult men and women with all stages of PD
- Without severe chronic neurological or mental or psychiatric pathology
- Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22)
- able to come (alone or accompanied) to consultation
- Affiliate or beneficiary of a social security scheme
- Subject having signed informed consent
- Patient willing to comply with all procedures of the study and its duration
- Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent.
- Subject under tutelage or curtailer.
- Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.
The study team makes the final eligibility decision.
Where it's taking place
- Lille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 7 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.